Insights into the epigenetic mechanisms controlling pancreatic carcinogenesis.
about
Current therapeutic strategies for advanced pancreatic cancer: A review for cliniciansPancreatic cancer: optimizing treatment options, new, and emerging targeted therapiesMiR-23a/-24-induced gene silencing results in mesothelial cell integration of pancreatic cancerThe Triple-Code Model for Pancreatic Cancer: Cross Talk Among Genetics, Epigenetics, and Nuclear StructureEpigenetics and pancreatic cancer: pathophysiology and novel treatment aspectsRole of non-coding RNAs in pancreatic cancer: the bane of the microworld.Bacterial quorum sensing molecule N-3-oxo-dodecanoyl-L-homoserine lactone causes direct cytotoxicity and reduced cell motility in human pancreatic carcinoma cellsGOT1/AST1 expression status as a prognostic biomarker in pancreatic ductal adenocarcinoma.Aberrant methylation patterns in cancer: a clinical view.System-Wide Associations between DNA-Methylation, Gene Expression, and Humoral Immune Response to Influenza Vaccination.Pivotal Role of the Chromatin Protein Nupr1 in Kras-Induced Senescence and Transformation.UHRF1 regulation of the Keap1-Nrf2 pathway in pancreatic cancer contributes to oncogenesisGLI1 finds a new role in cancer stem cell biology.Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinomaPancreatic cancer-associated retinoblastoma 1 dysfunction enables TGF-β to promote proliferation.Mechanistic insights into self-reinforcing processes driving abnormal histogenesis during the development of pancreatic cancerMicroRNA let-7 downregulates STAT3 phosphorylation in pancreatic cancer cells by increasing SOCS3 expression.Senescence in pancreatic carcinogenesis: from signalling to chromatin remodelling and epigenetics.Elevated STMN1 Expression Correlates with Poor Prognosis in Patients with Pancreatic Ductal Adenocarcinoma.Inhibition of S-Adenosylmethionine-Dependent Methyltransferase Attenuates TGFβ1-Induced EMT and Metastasis in Pancreatic Cancer: Putative Roles of miR-663a and miR-4787-5p.Loss of histone demethylase KDM6B enhances aggressiveness of pancreatic cancer through downregulation of C/EBPα.APC alterations are frequently involved in the pathogenesis of acinar cell carcinoma of the pancreas, mainly through gene loss and promoter hypermethylation.The promise of epigenomic therapeutics in pancreatic cancerClinical significance of RECK promoter methylation in pancreatic ductal adenocarcinoma.DLC-1 is a candidate biomarker methylated and down-regulated in pancreatic ductal adenocarcinoma.Long non-coding RNA in pancreatic adenocarcinoma and pancreatic neuroendocrine tumors.Class I histone deacetylase inhibition improves pancreatitis outcome by limiting leukocyte recruitment and acinar-to-ductal metaplasia.Targeting Epigenetic Aberrations in Pancreatic Cancer, a New Path to Improve Patient Outcomes?[Will molecular diagnostics become established in pancreatic pathology?].Association between heme oxygenase-1 gene promoter polymorphisms and cancer susceptibility: A meta-analysis.Omega-3 Fatty Acids Prevent Early Pancreatic Carcinogenesis via Repression of the AKT Pathway
P2860
Q26767041-24FFBA27-6BAA-4667-B839-5209570ECACAQ26799714-BC440774-1B45-4A0A-8B47-FBF9F1AE0A88Q27332271-A998B75F-B0F4-458B-8E62-9938D3224CCDQ28084785-1B2A19DC-9EE2-459A-A89A-276D89A8391CQ33801377-17C7269C-622F-463D-B509-494695BC2369Q33948361-0BC1CA65-DA6A-4D67-B14E-9C9C4F2DB376Q34133902-A02A6FC2-E5E9-4C3F-805C-26337AF7094FQ35552067-5315D29C-2833-4911-90CF-0FBC06560973Q35750355-00962A76-87CC-45AB-BCA5-9DECAE50A4B3Q35975551-F6CA0CAC-4D23-484A-82DB-777A7687B1EEQ36329451-D9052E0B-B902-4084-A2D3-08B117A4AF5EQ36536562-E816B0EE-5D2A-4026-8038-9A9CC0662B1FQ36771311-F1B87157-5762-4B44-92CF-47B844B730DBQ37123636-F971807B-052C-41CD-B1A9-7CB898551240Q37410628-90148E6A-4FC7-44DA-8D0B-169625BB6687Q37671861-5998EB5F-F02A-46D4-956A-3021FE7C4536Q37678651-AD370412-DDE5-453F-8F04-20764DDC432EQ38081391-33CD02E3-FFB9-4704-B1C4-F8D02F3EB692Q38387283-0C1ACA5A-07BA-4C35-803E-C65B323FB1BDQ38733932-171EF247-8823-4A84-95D2-D47FFECFAF49Q38982861-95F8830B-FF55-44BC-B3A8-EFEBE32939ECQ40174778-8D04B6F7-31B2-48CB-955F-54D7EF49DED7Q41473804-93D35645-8A6A-4A74-87E0-27E8A706C0A7Q44067402-105DB4FE-37B9-4E72-87BF-E1F84F0978CBQ45017704-C42D5EA4-CAA8-4A46-BED3-F339FF139798Q47099093-4C1BAD3C-C7BA-4EB3-A9C9-FF2B1ABB6EBBQ48194888-1A9623BE-641C-4BBF-9165-E3204622BAD5Q52715499-01DB7D45-4243-44DF-BD4F-878AA8BA89E7Q54397309-760BD57D-8324-4BF1-B1B9-83683CE8BA51Q55005099-EEEA32AC-5584-41BA-8FF0-5E43585701D7Q58745507-1441AAA0-A195-4226-A7B5-29C28BC7B2F2
P2860
Insights into the epigenetic mechanisms controlling pancreatic carcinogenesis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Insights into the epigenetic mechanisms controlling pancreatic carcinogenesis.
@en
type
label
Insights into the epigenetic mechanisms controlling pancreatic carcinogenesis.
@en
prefLabel
Insights into the epigenetic mechanisms controlling pancreatic carcinogenesis.
@en
P2093
P2860
P50
P1433
P1476
Insights into the epigenetic mechanisms controlling pancreatic carcinogenesis.
@en
P2093
Angela L McCleary-Wheeler
Gwen A Lomberk
Günter Schneider
Juan L Iovanna
Martin E Fernandez-Zapico
Raul Urrutia
Sandra Baumgart
Tara L Poshusta
Volker Ellenrieder
P2860
P304
P356
10.1016/J.CANLET.2012.10.005
P407
P577
2012-10-13T00:00:00Z